Liver fibrosis has adverse consequences, which range from cirrhosis to liver cancer. Liver fibrosis is a common outcome in most chronic liver diseases, particularly autoimmune hepatitis and non-alcoholic fatty liver disease. Fibrosis progression inevitably depends on the interruption of the autophagy pathway, a balance between survival and apoptosis in hepatic parenchymal cells, and interaction between the complex network of nonimmune cells involved in this physiological process, including stellate cell activation, hepatocytes apoptosis, recruitment of MSCs into the affected region by cytokines released from hepatic stellate cells (HSCs). Recent studies suggest that mesenchymal stem cells (MSCs) may be used for liver fibrosis treatment.
Many doctors have provided stem cell therapy for lung fibrosis in Delhi, and results are surprisingly in favor of the patients.
Remember, liver fibrosis is a common outcome for many types of chronic liver diseases. In advanced cases, this leads to cirrhosis, which currently has no effective treatment except for a rare function restoring therapy and liver transplantation. However, due to liver transplants' limitations, other therapies are badly needed to help restore some function back into the diseased organ before patients become too ill to undergo any transplants. Recent studies have found that mesenchymal stem cells (MSCs) could be an effective therapeutic strategy based on several studies showing they can be used as an active agent to promote regeneration and rejuvenate degenerative organs such as affected livers. If you are someone suffering from liver fibrosis and need an effective treatment, it’s hive time you contacted Dr. Rajput’s Stem Cell Research Center. Experts here will solemnly look into your case and will come up with the best solution for you.